Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Deciphera Receives Approval for ROMVIMZA™ (vimseltinib) in Tenosynovial Giant Cell Tumour (TGCT)
Thursday, September 18, 2025Deciphera Pharmaceuticals has received approval from the European Commission EC for ROMVIMZA vimseltinib to treat adult patients with symptomatic tenosynovial giant cell tumour TGCT in the European Union
Adagene Enters into Collaboration with Exelixis to Develop Third Masked Antibody-Drug Conjugate
Wednesday, September 17, 2025Adagene has expanded its collaboration and licence agreement with Exelixis to include a third antibodydrug conjugate ADC
VarmX Partners with CSL to Advance Novel Coagulation Treatment
Wednesday, September 17, 2025VarmX has entered into a strategic collaboration with CSL to support the development of its lead investigational therapy VMXC VMXC is a recombinant modified Factor X protein delivered as a rapid single dose to bypass anticoagulation activity and rest...
Akeso’s Ligufalimab Receives FDA Orphan Drug Designation for Acute Myeloid Leukaemia (AML)
Tuesday, September 16, 2025Akeso has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for its humanised IgG monoclonal antibody ligufalimab AK developed to target CD in the treatment of acute myeloid leukaemia AML
Daiichi Sankyo and Merck Receives FDA Breakthrough Therapy Designation for Raludotatug Deruxtecan in Ovarian and Related Cancers
Tuesday, September 16, 2025Daiichi Sankyo and Merck announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to their investigational antibodydrug conjugate raludotatug deruxtecan
Charles River Strengthens Oncology Manufacturing Portfolio to Advance Cell and Gene Therapy Research
Friday, September 12, 2025Charles River Laboratories International Inc has announced two new collaborations within its contract development and manufacturing organisation CDMO designed to advance oncology research and accelerate the development of cell and gene therapies for...
Scipher Medicine Enters into Partnership with Maxymune Therapeutics to Advance Autoimmune and Inflammatory Disease Research
Thursday, September 11, 2025Scipher Medicine has entered into a strategic collaboration with Maxymune TherapeuticsThe partnership will focus on accelerating target discovery in autoimmune and inflammatory diseases
Sanofi’s SAR402663 Receives US Fast Track Designation for Neovascular Age-Related Macular Degeneration
Thursday, September 11, 2025Sanofi has received Fast Track designation from the US Food and Drug Administration FDA for SAR a singledose intravitreal gene therapy being developed for the treatment of neovascular agerelated macular degeneration AMD
Teva’s Emrusolmin Receives U.S. FDA Fast Track Designation for Multiple System Atrophy
Wednesday, September 10, 2025Teva Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted Fast Track designation for its investigational therapy emrusolmin TEV for the treatment of Multiple System Atrophy MSA
Johnson & Johnson Receives FDA approval for INLEXZO™ in bladder cancer
Wednesday, September 10, 2025Johnson Johnson has received approval from the United States Food and Drug Administration FDA for INLEXZO gemcitabine intravesical system a new treatment for adults with nonmuscle invasive bladder
